Stay updated on DA-EPOCH-R+Nivolumab in Rearranged HGBL Clinical Trial

Sign up to get notified when there's something new on the DA-EPOCH-R+Nivolumab in Rearranged HGBL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DA-EPOCH-R+Nivolumab in Rearranged HGBL Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.3.1 to v3.3.2; no study content or data were changed.
    Difference
    0.0%
    Check dated 2025-12-01T12:52:30.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision: v3.3.1 was added and v3.2.0 removed. The page content, including study details and criteria, remains unchanged.
    Difference
    0.0%
    Check dated 2025-11-24T11:32:06.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    A government funding/status notice has been removed from the page. Core trial information, including the study title, interventions, eligibility criteria, outcomes, and locations, remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:15:37.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    No significant changes detected in core study information (title, purpose, eligibility, outcomes, or locations). Any differences appear to be minor UI/formatting tweaks.
    Difference
    0.3%
    Check dated 2025-11-03T00:53:07.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Update includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.
    Difference
    3%
    Check dated 2025-10-05T07:38:52.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Updated revision from v3.0.2 to v3.1.0 and added a new topic/resource on B-cell lymphoma.
    Difference
    0.4%
    Check dated 2025-09-28T02:59:01.000Z thumbnail image

Stay in the know with updates to DA-EPOCH-R+Nivolumab in Rearranged HGBL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DA-EPOCH-R+Nivolumab in Rearranged HGBL Clinical Trial page.